mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.085 |
0.2 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
BIRB 0796 |
GDSC1000 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
0.06 |
0.2 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
SB52334 |
GDSC1000 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |